BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,623,000 | +16.4% | 367,537 | -8.1% | 1.13% | +9.2% |
| Q1 2017 | $15,996,000 | +1855.5% | 400,000 | +1352.5% | 1.04% | +1496.9% |
| Q3 2016 | $818,000 | +42.5% | 27,539 | -2.9% | 0.06% | +18.2% |
| Q2 2016 | $574,000 | +17.6% | 28,353 | +4.8% | 0.06% | +10.0% |
| Q1 2016 | $488,000 | -93.3% | 27,055 | -90.2% | 0.05% | -90.8% |
| Q4 2015 | $7,288,000 | -7.1% | 276,687 | -24.7% | 0.54% | -8.2% |
| Q3 2015 | $7,842,000 | -18.9% | 367,485 | -2.8% | 0.59% | -25.1% |
| Q2 2015 | $9,671,000 | – | 378,235 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |